Opendata, web and dolomites

ASTROCIT

Development and validation of an innovative nutritional solution to fight muscle atrophy during human space flights, application of the acquired knowledge to prevent muscle degeneration down on earth

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ASTROCIT project word cloud

Explore the words cloud of the ASTROCIT project. It provides you a very rough idea of what is the project "ASTROCIT" about.

compounds    combination    consolidating    50    solutions    underwent    nutraceutical    innovative    diet    giving    cared    prevent    bioavailability    health    effect    feasibility    therapeutic    commercially    plan    autonomy    people    clinical    formulation    earth    quantify    expertise    bettering    compliancy    flights    muscular    business    acids    satisfactory    ip    fight    serious    lasting    someone    nutrition    strategy    financial    physicians    performance    collecting    protocol    benefit    hitherto    reducing    gerontologists    medical    severely    citrage    deliverable    amino    physiotherapists    backing    commercializing    astrocit    older    space    risks    thereby    weightlessness    atrophy    proven    opportunity    quality    spending    unseen    validate    preventive    life    missions    revolutionize    ageing    ease    data    degeneration    surgery    astronaut    huge    instance    muscle    immobilization    public    aged    injured    updated    hardly    answer    scientific    efficiency    person    solution    first    human    exercise    routine    industrial    seize    question    mass    accessing    galenics    mitigate    astronauts    lose   

Project "ASTROCIT" data sheet

The following table provides information about the project.

Coordinator
CITRAGE 

Organization address
address: 94 AV GENERAL DE GAULLE
city: CRETEIL
postcode: 94019
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.citrage.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.6. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Space)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-03-01   to  2016-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CITRAGE FR (CRETEIL) coordinator 50˙000.00

Map

 Project objective

Question: What is the common factor between an astronaut, an older person and someone who just underwent a serious surgery? Answer: Muscle atrophy. During long missions for instance, astronauts can lose up to 50% of their muscle mass severely affecting their performance and health. The only commercially available solutions hardly able to mitigate the effect of weightlessness, ageing and immobilization are exercise and diet but they are not satisfactory in terms of efficiency, ease-of-use, bioavailability, compliancy or scientific backing. AstroCIT’s objective is to develop and validate an innovative nutraceutical to fight muscle loss during human space flights and prevent muscular degeneration on earth. It will revolutionize how muscle atrophy is cared for by giving space physicians, gerontologists and physiotherapists an effective preventive and therapeutic solution, thereby enabling astronauts to be more operational, bettering quality of life in space, improving autonomy of aged or injured people and reducing public spending. This new nutraceutical is based on CITRAGE’s and its partners’ long lasting expertise in developing and commercializing amino acids based products applied to the combination of a proven and a hitherto unseen compounds. During phase 1, CITRAGE will scale-up the project by (a) defining the best formulation and galenics for the product, (b) accessing data generated by other research projects in the field of nutrition and muscle atrophy, (c) collecting medical and financial data to further quantify the technology’s benefit and its risks, (d) defining the protocol of a EU clinical study to be implemented in phase 2 and (e) consolidating the IP strategy. The main deliverable will be an updated business plan enabling CITRAGE to seize this huge business opportunity of further exploiting their know-how in space and down on earth. This feasibility study is an essential first step before routine use and industrial production.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ASTROCIT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ASTROCIT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.6.;H2020-EU.2.3.1.)

ReadyToSail (2016)

ReadyToSail

Read More  

HEART (2018)

HIGH HEAT REJECTION THERMAL CONTROL SYSTEM

Read More  

SPS_TFP_SQ (2015)

TFP Strut Qualification

Read More